ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

KDNY Chinook Therapeutics Inc

40,39
0,00 (0,00%)
21 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Chinook Therapeutics Inc KDNY NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 40,39 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
40,39 40,39
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/11/202322:15EDGAR2Form SC 13D/A - General statement of acquisition of..
21/8/202319:21EDGAR2Form 15-12G - Securities registration termination [Section..
17/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
11/8/202323:02EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/8/202322:39EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
11/8/202322:35EDGAR2Form POS AM - Post-Effective amendments for registration..
11/8/202322:31EDGAR2Form 8-K - Current report
11/8/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:06EDGAR2Form 8-K - Current report
02/8/202301:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202313:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/7/202314:15EDGAR2Form 8-K - Current report
28/7/202314:00GLOBEChinook Therapeutics Announces First Patient Enrolled in..
26/7/202322:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/7/202322:01EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
17/6/202313:15GLOBEChinook Therapeutics Presents Data from CHK-336 Phase 1..
12/6/202322:00GLOBEChinook Therapeutics to Present Updated Data from Zigakibart..
12/6/202316:40DJNTrending: Novartis Buying Chinook Therapeutics for Up to..
12/6/202314:09DJNFlurry of European Companies Engaged in Acquisitions, Asset..
12/6/202308:08DJFRNovartis va acquérir Chinook Therapeutics pour 3,5 milliards..
12/6/202307:53DJNNovartis to Acquire Chinook Therapeutics for Up to $3.5..
12/6/202307:00GLOBEChinook Therapeutics Enters into Agreement to be Acquired by..

Dernières Valeurs Consultées